Stifel bumps Nvidia stock target, sees attractive valuation
Global Medical REIT Inc (NYSE:GMRE)., a Maryland-based real estate investment trust, announced the results of its annual meeting held on May 14, 2025. The company’s stockholders elected seven directors to its board, each to serve until the 2026 annual meeting. Additionally, stockholders approved executive compensation on an advisory basis and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The detailed voting results for the election of directors showed that all seven nominees were elected with a significant majority. The votes for each director ranged from 37,832,272 to 39,472,513 in favor, with broker non-votes ranging from 12,876,137 to 12,876,141. The advisory vote on named executive officer compensation resulted in 37,832,272 votes for, 1,401,327 against, and 759,248 abstentions, with 12,876,141 broker non-votes. The ratification of Deloitte & Touche LLP received 52,540,491 votes for, 211,931 against, and 116,566 abstentions, with no broker non-votes.
These decisions were made as part of the company’s 2025 annual meeting of stockholders, which is a routine process for publicly traded companies to engage with their shareholders on governance and other important issues. The company, which is incorporated in Maryland, has its shares registered on the New York Stock Exchange under the trading symbols GMRE for its common stock and GMRE PrA for its preferred stock. InvestingPro subscribers can access detailed financial analysis, including 10 key ProTips and comprehensive valuation metrics in the Pro Research Report, helping investors make more informed decisions about this REIT.
The announcement is based on a press release statement and provides an overview of the key decisions made by the stockholders of Global Medical REIT Inc. during their recent annual meeting.
In other recent news, Global Medical REIT Inc. reported its financial results for the first quarter of 2025, revealing a mixed performance. The company achieved earnings per share of 3 cents, exceeding analysts’ expectations of 1 cent. However, revenue fell short at $34.6 million, compared to the anticipated $35.34 million. The company reaffirmed its full-year 2025 Adjusted Funds from Operations (AFFO) guidance of $0.89 to $0.93 per share. Additionally, Global Medical (TASE:BLWV) REIT completed the acquisition of a five-property portfolio for $69.6 million, which aligns with its strategic focus on acquisition growth. The company also completed the sale of two medical properties, generating gross proceeds of $8.2 million and a gain of $1.4 million. Analysts from firms such as KeyBanc and BMO have been inquiring about the company’s leasing strategies and potential impacts from tenant bankruptcies. Despite these challenges, the management remains optimistic about maintaining high occupancy rates and exploring further acquisition opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.